Analyst Ratings for ISIS Pharmaceuticals (isis)

isis Rating Summary

isis Price Target Summary

* Over Last 12-Mos
  |   Expand Research on isis
Overall Rating: NEUTRAL   Rating Trend: Up   Avg. $ Target: $49.33 (+56%) * Over Last 12-Mos
Date Firm Type Rating
(Past)
PT
(Past)
Start $ End $ % Chg. Details
5/6/2014 Piper Jaffray
» Updated 5/23/2014
Upgrade Overweight
(Neutral)
42.00
(N/A)
25.60 31.62 23.52% Details
1/22/2014 Deutsche Bank
» Updated 5/22/2014
New Coverage Buy
(N/A)
60.00
(N/A)
48.00 31.62 -34.13% Details
Like ISIS Ratings? Also take a look at SNY, SAN, BIIB, GSK

ISIS Ratings News